Is Canopy Growth Corp. (TSX:WEED) Stock a Buy Below $30?

The downward trend in marijuana stocks continues to send share prices to new 12-month lows. This is a very different situation compared to the massive rally the sector enjoyed in the first two weeks of last October ahead of the launch of the legal recreational market in Canada. Canopy Growth (TSX:WEED)(NYSE:CGC) traded above $73 per share on October 15, 2018.…

Read More

Why Aurora Cannabis (TSX:ACB) Is Still Overvalued

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) is a stock that has seen better years. After starting the year at $7.09, it has since fallen to $5.82–a 13.6% decline. On Aurora’s bumpy ride, there have been opportunities for short term traders to make money. However, the stock has overall been a losing proposition–particularly since March. When you’ve got a stock that’s falling while growing…

Read More

KALY – Kali-Extracts Confirms CBD Extract Biopharmaceutical Business Update Scheduled Monday October 7, 2019

Kali Extracts

DALLAS, Oct. 03, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company has schedule a presentation for next week on Monday, October 7, 2019 to communicate its latest Cannabis Extract Biopharmaceutical developments. The presentation will also include updates on the company’s consumer cannabis extract business which is…

Read More

Is Green Organic Dutchman (TSX:TGOD) a Steal at $2?

Green Organic Dutchman Holdings (TSX:TGOD) had a very bad month of September, declining around 40%. You know it’s bad when CannTrust, a company that had its licence suspended, didn’t have as big of a drop during the month. TGOD finished September at just over $2 a share, as it hit a new 52-week low. Why have investors been down on the…

Read More

Go Long on “Big Cannabis” and Ignore Edibles?

Unless you’re a momentum trader looking for some quick upside, the legalization of edibles next month should be given a wide berth by long-term investors. Instead, a low-risk, long-range position in a big player such as Canopy Growth (TSX:WEED)(NYSE:CGC) may seem the wisest option for newcomers looking to gain upside from the cannabis industry. The rebooted cannabis space may be…

Read More

TFSA Investors: Should You Own Marijuana Stocks?

Marijuana stocks have been a hot news item over the past two years. Between legalization, global expansion and massive M&A deals, there’s been a lot to keep up with. In the lead-up to legalization, weed stocks went on a massive bull run, with stocks like Tilray Inc (NASDAQ:TLRY) rising nearly 1000% in just a few months. Since then, the marijuana sector…

Read More

Investors: Is This Cannabis Stock on the Verge of a Breakout?

Shares of The Supreme Cannabis Company (TSX:FIRE) have generated marginal returns since listing as a public company in June 2017. The stock closed trading at $1.35 per share on June 9, 2017, and is currently trading at $1.38 per share at writing. It reached an all-time high of $3.04 in January 2018, and it looked like FIRE shares were making…

Read More

Should You Buy Canopy Growth (TSX:WEED) or CIBC (TSX:CM) Stock Today?

Pot stocks and banks have fallen out of favour with the market in the past few months, and that has contrarian investors wondering if this might be a good time to add unloved marijuana stocks or financials to their portfolios. Let’s take a look at Canopy Growth (TSX:WEED)(NYSE:CGC) and Canadian Imperial Bank of Commerce (TSX:CM)(NYSE:CM) to see if one deserves…

Read More

Why Curaleaf Holdings (CNSX:CURA) Rose 10% in the Last Week

Shares of leading cannabis company Curaleaf Holdings (CNSX:CURA) have risen 10% in the last week of August 2019. The stock is currently trading at $9.41. Despite the recent rally, Curaleaf shares are still trading 40% below their 52-week high. Stock rose despite missing revenue and earnings estimate Curaleaf is a Canada-based vertically integrated cannabis company in the U.S. Curaleaf announced…

Read More

KALY- Kali-Extracts Analyst Report Speculating $0.05 PPS On Recent Biopharmaceutical Cannabis Extract Progress Updated To Website

DALLAS, Aug. 27, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a new analyst report covering the company’s recent biopharmaceutical cannabis extract business development updates. The report has been released by Goldman Small Cap Research after market today, August 27, 2019, and can be found on Goldman’s website…

Read More